Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$484K Sell
3,766
-9,100
-71% -$1.07M 0.02% 243
2026
Q1
$1.55M Sell
12,866
-1,054
-8% -$122K 0.08% 130
2025
Q4
$1.47M Buy
13,920
+7,250
+109% +$681K 0.08% 132
2025
Q3
$560K Buy
+6,670
New +$549K 0.03% 209
2025
Q1
Sell
-26,569
Closed -$2.64M 297
2024
Q4
$2.64M Sell
26,569
-1,008
-4% -$104K 0.21% 89
2024
Q3
$3.13M Sell
27,577
-1,311
-5% -$156K 0.24% 78
2024
Q2
$3.58M Sell
28,888
-4,153
-13% -$535K 0.33% 55
2024
Q1
$4.36M Sell
33,041
-4,044
-11% -$498K 0.37% 50
2023
Q4
$4.04M Sell
37,085
-7,392
-17% -$767K 0.34% 48
2023
Q3
$4.58M Sell
44,477
-6,361
-13% -$686K 0.4% 53
2023
Q2
$5.87M Sell
50,838
-996
-2% -$113K 0.48% 50
2023
Q1
$5.51M Sell
51,834
-2,754
-5% -$297K 0.51% 52
2022
Q4
$6.06M Sell
54,588
-3,792
-6% -$388K 0.52% 43
2022
Q3
$5.03M Sell
58,380
-1,484
-2% -$132K 0.5% 53
2022
Q2
$5.46M Sell
59,864
-327
-0.5% -$29K 0.55% 49
2022
Q1
$4.94M Buy
60,191
+43
+0.1% +$3.39K 0.43% 74
2021
Q4
$4.61M Buy
60,148
+1,972
+3% +$157K 0.34% 84
2021
Q3
$4.37M Buy
58,176
+2,226
+4% +$169K 0.36% 81
2021
Q2
$4.35M Sell
55,950
-9,221
-14% -$686K 0.36% 76
2021
Q1
$4.79M Sell
65,171
-23,477
-26% -$1.73M 0.44% 59
2020
Q4
$6.92M Buy
88,648
+3,213
+4% +$246K 0.6% 42
2020
Q3
$6.76M Sell
85,435
-2,006
-2% -$157K 0.73% 40
2020
Q2
$6.45M Sell
87,441
-21,816
-20% -$1.64M 0.76% 35
2020
Q1
$8.03M Sell
109,257
-2,263
-2% -$178K 1.06% 18
2019
Q4
$9.68M Buy
111,520
+4,152
+4% +$341K 0.92% 23
2019
Q3
$8.62M Buy
107,368
+10,976
+11% +$880K 0.89% 25
2019
Q2
$7.71M Buy
96,392
+8,649
+10% +$662K 1.04% 20
2019
Q1
$6.96M Sell
87,743
-16,371
-16% -$1.22M 0.94% 24
2018
Q4
$7.59M Buy
+104,114
New +$7.35M 0.55% 30

Other funds holding MRK

Sepio Capital's MRK Position: Q2 2026 in Review

Sepio Capital reduced its Merck (MRK) stake by 71% in Q2 2026, selling an estimated $1.07M and leaving 3,766 shares worth $484K. The position accounts for 0.02% of the portfolio, ranked #243.

Sepio Capital first reported a position in MRK in Q4 2018 and has held it in 29 quarters since. The position peaked at $9.68M in Q4 2019. 1,835 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Sepio Capital held 3,766 shares of Merck worth $484K as of Q2 2026.
  • Sepio Capital sold 9,100 Merck shares in Q2 2026, an estimated $1.07M.
  • Merck made up 0.02% of Sepio Capital's portfolio in Q2 2026, its #243 holding.
  • Sepio Capital first reported a position in Merck in Q4 2018 and has held it in 29 quarters since.
  • Sepio Capital's Merck position peaked at $9.68M in Q4 2019.
  • 1,835 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Sepio Capital's 13F filing for Q2 2026, filed 28 Jul 2026.